Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06400459 · ClinicalTrials.gov registry record · Phase 1
IVW-1001 Phase 1/2 in Subjects With Dry Eye Disease
A Phase 1 study, sponsored by IVIEW Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 150
- Enrollment target
NCT06400459: Completed Phase 1 study, sponsored by IVIEW Therapeutics.
NCT06400459 is a Phase 1 study that has completed, run by IVIEW Therapeutics. The registered enrollment target is 150 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (150% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06400459, a Phase 1 study, has completed, sponsored by IVIEW Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 150 participants
- Enrollment target
Study Summary
Double-masked, dose-response, trial of IVW-1001 in subjects with dry eye disease.
Primary Outcome
Mean change from baseline in study eye in unanesthetized measure of tear product using Schirmer strip (measured in mm of wetness)
Interventions
- DRUG IVW-1001 Ophthalmic Eyelid Wipe 0.2%
- DRUG IVW-1001 Ophthalmic Eyelid Wipe 0.1%
- DRUG IVW-1001 Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-06-25 |
| Est. Completion | 2024-10-15 |
| Phase | Phase 1 |
What the finished NCT06400459 record still lists
NCT06400459 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (150% higher).
The record links to 0 conditions, and to 3 interventions - of which IVW-1001 Ophthalmic Eyelid Wipe 0.2% is the first listed.
NCT06400459 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06400459 about?
NCT06400459 is a clinical study titled "IVW-1001 Phase 1/2 in Subjects With Dry Eye Disease". Double-masked, dose-response, trial of IVW-1001 in subjects with dry eye disease.
What is the current status of trial NCT06400459?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 150 participants. The study started on 2024-06-25. Estimated completion is 2024-10-15.
What interventions are being tested in trial NCT06400459?
The interventions under investigation include: IVW-1001 Ophthalmic Eyelid Wipe 0.2% (DRUG), IVW-1001 Ophthalmic Eyelid Wipe 0.1% (DRUG), IVW-1001 Placebo (DRUG).
Who is sponsoring clinical trial NCT06400459?
This trial is sponsored by IVIEW Therapeutics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06400459's enrollment target sits among peer trials
150 363rd of 2000 higher than 1,620 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI